These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8344170)

  • 1. [Coagulation parameters in high-dosage intravenous heparin therapy].
    Hafner G
    Dtsch Med Wochenschr; 1993 Aug; 118(31):1131-2. PubMed ID: 8344170
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monitoring of heparin therapy using thrombin time and activated partial thromboplastin time--a comparison].
    Osterwalder J
    Schweiz Med Wochenschr; 1987 Apr; 117(14):539-40. PubMed ID: 3576165
    [No Abstract]   [Full Text] [Related]  

  • 3. [Laboratory controls of heparin therapy with thrombin time, partial thromboplastin time and activated recalcification time].
    Lutze G; Presser HJ; Urbahn H
    Z Gesamte Inn Med; 1989 Apr; 44(8):235-40. PubMed ID: 2662657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin time dilution test: a simple method for the control of heparin therapy.
    Pizzuto J; García-Méndez S; de-la-Paz Reyna M; Morales MR; Avilés A; Zavala B; Gaos C
    Thromb Haemost; 1979 Dec; 42(4):1276-85. PubMed ID: 542933
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood-sampling strategy for monitoring continuous intravenous heparin therapy.
    Chenella FC; Klotz TA; Gill MA; Paulson YJ; Noguchi JK; Hurst AK; Robinson DC; Hill-Besinque K; Clifford CM; McGehee WG
    Clin Pharm; 1986 Jun; 5(6):510-3. PubMed ID: 3720219
    [No Abstract]   [Full Text] [Related]  

  • 6. [Heparin and antiheparin in childhood. 3. Heparin level measurements and their importance in heparin monitoring].
    Domula M; Weissbach G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):146-61. PubMed ID: 6192049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R; Jacobs C
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
    Ray PK; Harper TA
    J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859
    [No Abstract]   [Full Text] [Related]  

  • 9. [Heparin therapy and its monitoring].
    Camici M; Evangelisti L
    Clin Ter; 1991 Feb; 136(4):279-82. PubMed ID: 1827391
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin: clinical or distributive problem?
    Vogenberg FR; Mantel SA
    Am J Hosp Pharm; 1982 Nov; 39(11):1854, 1856. PubMed ID: 7148849
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of deep venous thrombosis].
    Mesters RM
    Internist (Berl); 1999 Oct; 40(10):1098-9. PubMed ID: 10610366
    [No Abstract]   [Full Text] [Related]  

  • 12. Monitoring the intrinsic pathway of coagulation during heparin therapy.
    Hoffmann JJ
    Thromb Haemost; 1985 Feb; 53(1):161. PubMed ID: 3992518
    [No Abstract]   [Full Text] [Related]  

  • 13. Coagulation studies and the indwelling heparinized catheter.
    Molyneaux RD; Papciak B; Rorem DA
    Heart Lung; 1987 Jan; 16(1):20-3. PubMed ID: 3641823
    [No Abstract]   [Full Text] [Related]  

  • 14. The activated partial thromboplastin time.
    Chin JL
    N Engl J Med; 1973 Jun; 288(26):1410. PubMed ID: 4707428
    [No Abstract]   [Full Text] [Related]  

  • 15. [The coagulation parameters in high-dosage intravenous heparin therapy].
    Weidmann B
    Dtsch Med Wochenschr; 1994 Mar; 119(12):442. PubMed ID: 8143564
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
    Bremme K; Lind H; Blombäck M
    Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin assay methods for control of in vivo heparin effects.
    Godal HC
    Thromb Diath Haemorrh; 1975 Feb; 33(1):77-80. PubMed ID: 1091021
    [No Abstract]   [Full Text] [Related]  

  • 18. Coagulation assays.
    Bates SM; Weitz JI
    Circulation; 2005 Jul; 112(4):e53-60. PubMed ID: 16043649
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of point-of-care activated partial thromboplastin time testing by comparison to laboratory-based assay for control of intravenous heparin.
    Douglas AD; Jefferis J; Sharma R; Parker R; Handa A; Chantler J
    Angiology; 2009; 60(3):358-61. PubMed ID: 19398428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.